Adaptimmune Therapeutics ADAP reported its Q4 earnings results on Monday, March 14, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Adaptimmune Therapeutics missed estimated earnings by 128.57%, reporting an EPS of $-0.04 versus an estimate of $0.14.
Revenue was down $85.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 4.19% increase in the share price the next day.
Here's a look at Adaptimmune Therapeutics's past performance:
|Quarter||Q3 2021||Q2 2021||Q1 2021||Q4 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.